Bullous pemphigoid and related subepidermal autoimmune blistering diseases

Current Directions in Autoimmunity

Volumn 10, Issue , 2008, Pages 141-166

  Olasz, E ^a,b   Yancey, K ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; BASEMENT MEMBRANE; BLISTER; BULLOUS PEMPHIGOID; EPIDERMIS; HUMAN; IMMUNOLOGY; MORTALITY; PATHOLOGY; REVIEW;

ANIMALS; AUTOANTIBODIES; BASEMENT MEMBRANE; BLISTER; EPIDERMIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PEMPHIGOID, BULLOUS;

EID: 49049111187     PISSN: 14222132     EISSN: 16622936     Source Type: Book Series    
DOI: 10.1159/000131452     Document Type: Review

References (28)

1. Yancey KB: The pathophysiology of autoimmune blistering diseases. J Clin Invest 2005;115:825-828.
2. Yancey KB, Egan CA: Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA 2000;284:350-356.
3. Masunaga T: Epidermal basement membrane: its molecular organization and blistering disorders. Connect Tissue Res 2006;47:55-66.
4. Borradori L, Sonnenberg A: Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 1999;112:411-418.
5. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI: Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 1981;24:897-903.
6. Labib RA, Anhalt GJ, Patel HP, Mutsim DF, Diaz LA: Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986;136:1231-1235.
7. Diaz LA, Ratrie H 3rd, Saunders WS, Futamura S, Squiquera HL, Anhalt GJ, Giudice GJ: Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest 1990;86:1088-1094.
8. Van den Bergh F, Giudice GJ: BP180 (type XVII collagen) and its role in cutaneous biology and disease. Adv Dermatol 2003;19:37-71.
9. Zillikens D, Giudice GJ: BP180/type XVII collagen: its role in acquired and inherited disorders or the dermal-epidermal junction. Arch Dermatol Res 1999;291:187-194.
10. Hall RP 3rd, Murray JC, McCord MM, Rico MJ, Streilein RD: Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid. J Invest Dermatol 1993;101:9-14.
11. Zillikens D, Rose PA, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, Giudice GJ: Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 1997;109:573-579.
12. Hertl M, Eming R, Veldman C: T cell control in autoimmune bullous skin disorders. J Clin Invest 2006;116:1159-1166.
13. Fairley JA, Fu CL, Giudice GJ: Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. J Invest Dermatol 2005;125:467-472.
14. Kiss M, Husz S, Janossy T, Marczinovits I, Molnar J, Korom I, Dobozy A: Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230. J Autoimmun 2005;24:1-10.
15. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ: A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993;92:2480-2488.
16. Olasz EB, Roh J, Yee CL, Arita K, Akiyama M, Shimizu H, Vogel JC, Yancey KB: Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice. J Invest Dermatol 2007;127:2807-2817.
17. Nishie W, Sawamura D, Goto M, Ito K, Shibaki A, McMillan JR, Sakai K, Nakamura H, Olasz E, Yancey KB, Akiyama M, Shimizu H: Humanization of autoantigen. Nat Med 2007;13:378-383.
18. Yancey KB: Cicatricial pemphigoid; in Freedburg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds): Fitzpatrick's Dermatology in General Medicine, ed 5. New York, McGraw-Hill, 2002, pp 674-680.
19. Bedane C, McMillan JR, Balding SD, Bernard P, Prost C, Bonnetblanc JM, Diaz LA, Eady RA, Giudice GJ: Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol 1997;108:901-907.
20. Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB: Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 1992;90:1628-1633.
21. Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB: Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 1995;105:543-548.
22. Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB: Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 1996;98:1509-1518.
23. Jenkins RE, Hern S, Black MM: Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol 1999;24:255-259.
24. Katz SI, Hertz KC, Yaoita H: Herpes gestationis. Immunopathology and characterization of the HG factor. J Clin Invest 1976;57:1434-1441.
25. Egan CA, Zone JJ: Linear IgA bullous dermatosis. Int J Dermatol 1999;38:818-827.
26. Wojnarowska F: Chronic bullous disease of childhood. Semin Dermatol 1988;7:58-65.
27. Zone JJ, Egan CA, Taylor TB, Meyer LJ: IgA autoimmune disorders: development of a passive transfer mouse model. J Investig Dermatol Symp Proc 2004;9:47-51.
28. Harting MS, Hsu S: Lichen planus pemphigoides: a case report and review of the literature. Dermatol Online J 2006;12:10.